Literature DB >> 34374752

Distinct mitochondria-mediated T cells apoptosis responses in children and adults with COVID-19.

Yang Yang1,2, Kuang Liangjian1, Linhai Li2, Wu Yongjian1,2, Bei Zhong2, Xi Huang1,2.   

Abstract

BACKGROUND: Lymphopenia is a key feature for adult patients with coronavirus disease 2019 (COVID-19), while it is rarely observed in children. The underlying mechanism remains unclear.
METHODS: Immunohistochemical and flow cytometric analyses were used to compare the apoptotic rate of T cells from COVID-19 adults and children and apoptotic responses of adult and child T cells to COVID-19 pooled plasma. Biological properties of caspases and reactive oxygen species were assessed in T cells treated by COVID-19 pooled plasma.
RESULTS: Mitochondria apoptosis of peripheral T cells were identified in COVID-19 adult patient samples, but not in the children. Furthermore, increased TNF-α and IL-6 in COVID-19 plasma induced mitochondria apoptosis and caused DNA damage by elevating reactive oxygen species levels of the adult T cells. However, the child T cells showed tolerance to mitochondrial apoptosis due to mitochondria autophagy. Activation of autophagy could decrease apoptotic sensitivity of the adult T cells to plasma from COVID-19 patients.
CONCLUSIONS: Our results indicated that the mitochondrial apoptosis pathway was activated in T cells of COVID-19 adult patients specifically, which may shed light on the pathophysiological difference between adults and children infected with SARS-CoV-2.
© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  COVID-19; adult; children; lymphopenia; mitochondria apoptosis

Year:  2021        PMID: 34374752     DOI: 10.1093/infdis/jiab400

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  5 in total

1.  Immune-Related Protein Interaction Network in Severe COVID-19 Patients toward the Identification of Key Proteins and Drug Repurposing.

Authors:  Pakorn Sagulkoo; Apichat Suratanee; Kitiporn Plaimas
Journal:  Biomolecules       Date:  2022-05-11

2.  SARS-CoV-2 membrane protein causes the mitochondrial apoptosis and pulmonary edema via targeting BOK.

Authors:  Yang Yang; Yongjian Wu; Xiaojun Meng; Zhiying Wang; Muhammad Younis; Ye Liu; Peihui Wang; Xi Huang
Journal:  Cell Death Differ       Date:  2022-01-12       Impact factor: 12.067

3.  Mitochondrial Dysfunction Associates With Acute T Lymphocytopenia and Impaired Functionality in COVID-19 Patients.

Authors:  Yufei Mo; Kelvin Kai-Wang To; Runhong Zhou; Li Liu; Tianyu Cao; Haode Huang; Zhenglong Du; Chun Yu Hubert Lim; Lok-Yan Yim; Tsz-Yat Luk; Jacky Man-Chun Chan; Thomas Shiu-Hong Chik; Daphne Pui-Ling Lau; Owen Tak-Yin Tsang; Anthony Raymond Tam; Ivan Fan-Ngai Hung; Kwok-Yung Yuen; Zhiwei Chen
Journal:  Front Immunol       Date:  2022-01-14       Impact factor: 7.561

Review 4.  Roles of host mitochondria in the development of COVID-19 pathology: Could mitochondria be a potential therapeutic target?

Authors:  Kavya Srinivasan; Ashutosh Kumar Pandey; Ashlena Livingston; Sundararajan Venkatesh
Journal:  Mol Biomed       Date:  2021-11-23

5.  NSP4 and ORF9b of SARS-CoV-2 Induce Pro-Inflammatory Mitochondrial DNA Release in Inner Membrane-Derived Vesicles.

Authors:  Md Imam Faizan; Rituparna Chaudhuri; Shakti Sagar; Sarah Albogami; Nisha Chaudhary; Iqbal Azmi; Areej Akhtar; Syed Mansoor Ali; Rohit Kumar; Jawed Iqbal; Mohan C Joshi; Gaurav Kharya; Pankaj Seth; Soumya Sinha Roy; Tanveer Ahmad
Journal:  Cells       Date:  2022-09-23       Impact factor: 7.666

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.